Premium
Trisomy 12 is a consistent chromosomal aberration in benign ovarian tumors
Author(s) -
Pejovic Tanja,
Heim Sverre,
Mandahl Nils,
Elmfors Bengt,
Flodérus UllaMaria,
Furgyik Stefan,
Helm Góran,
Willén Helena,
Mitelman Felix
Publication year - 1990
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.2870020109
Subject(s) - pathology , serous cystadenoma , trisomy , cystadenoma , mucinous cystadenoma , ovarian tumor , karyotype , biology , trisomy 8 , serous fluid , ovary , chromosome , medicine , ovarian cancer , cancer , genetics , pancreas , gene , biochemistry
Clonal karyotypic abnormalities were detected in 7 of 42 cytogenetically analyzed benign ovarian tumors. An adenofibroma had –X and a mucinous cystadenoma had t(1;11)(q25;q23) as the sole abnormality. Trisomy 12 was found in the remaining five tumors. It was the only change in two fibromas and a serous cystadenoma; the fourth tumor, a mucinous cystadenoma, had one clone with + 12 and one with + 12 and + 10, and the fifth tumor, a fibrothecoma, had +4, +9, +12. The finding of trisomy 12 in five of seven karyotypically aberrant tumors suggests that this aberration characterizes a hitherto unrecognized cytogenetic subgroup of benign ovarian neoplasms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom